Kang Sun's most recent trade in Amprius Technologies Inc was a trade of 62,101 Common stock done at an average price of $10.3 . Disclosure was reported to the exchange on Aug. 21, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | Sale of securities on an exchange or to another person at price $ 10.34 per share. | 21 Aug 2026 | 62,101 | 1,218,397 | - | 10.3 | 642,186 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | Sale of securities on an exchange or to another person at price $ 17.19 per share. | 27 May 2026 | 356 | 1,280,498 | - | 17.2 | 6,121 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | Sale of securities on an exchange or to another person at price $ 14.79 per share. | 21 May 2026 | 67,796 | 1,280,854 | - | 14.8 | 1,002,594 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2026 | 6,250 | 1,348,650 | - | 0 | Common stock | |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.78 per share. | 01 Apr 2026 | 1,312,505 | 2,654,905 | - | 1.8 | 2,336,259 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | 01 Apr 2026 | 1,312,505 | 0 | - | - | Stock Option (right to buy) | ||
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | Sale of securities on an exchange or to another person at price $ 15.73 per share. | 01 Apr 2026 | 1,250,963 | 1,591,437 | - | 15.7 | 19,681,151 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | Sale of securities on an exchange or to another person at price $ 16.78 per share. | 01 Apr 2026 | 249,037 | 1,342,400 | - | 16.8 | 4,179,563 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | 01 Apr 2026 | 187,495 | 1,787,007 | - | - | Stock Option (right to buy) | ||
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.68 per share. | 01 Apr 2026 | 187,495 | 2,842,400 | - | 3.7 | 689,982 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | Sale of securities on an exchange or to another person at price $ 18.69 per share. | 23 Mar 2026 | 152,823 | 121,452 | - | 18.7 | 2,855,696 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | Sale of securities on an exchange or to another person at price $ 19.06 per share. | 23 Mar 2026 | 65,046 | 56,406 | - | 19.1 | 1,239,705 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | Sale of securities on an exchange or to another person at price $ 10.16 per share. | 23 Feb 2026 | 61,251 | 1,342,400 | - | 10.2 | 622,035 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | Sale of securities on an exchange or to another person at price $ 11.07 per share. | 16 Jan 2026 | 950,548 | 1,403,651 | - | 11.1 | 10,518,669 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 16 Jan 2026 | 850,338 | 2,253,989 | - | 2.5 | 2,125,845 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | 16 Jan 2026 | 850,338 | 0 | - | - | Stock Option (right to buy) | ||
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.78 per share. | 16 Jan 2026 | 100,210 | 2,354,199 | - | 1.8 | 178,374 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | 16 Jan 2026 | 100,210 | 1,355,690 | - | - | Stock Option (right to buy) | ||
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | 16 Jan 2026 | 43,185 | 1,312,505 | - | - | Stock Option (right to buy) | ||
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.78 per share. | 16 Jan 2026 | 43,185 | 1,446,836 | - | 1.8 | 76,869 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | Sale of securities on an exchange or to another person at price $ 11.03 per share. | 16 Jan 2026 | 43,185 | 1,403,651 | - | 11.0 | 476,274 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | Sale of securities on an exchange or to another person at price $ 10.10 per share. | 12 Jan 2026 | 506,267 | 1,403,651 | - | 10.1 | 5,111,474 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.44 per share. | 12 Jan 2026 | 208,264 | 1,792,717 | - | 2.4 | 508,164 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | 12 Jan 2026 | 208,264 | 0 | - | - | Stock Option (right to buy) | ||
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.62 per share. | 12 Jan 2026 | 180,802 | 1,584,453 | - | 0.6 | 112,097 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | 12 Jan 2026 | 180,802 | 0 | - | - | Stock Option (right to buy) | ||
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 12 Jan 2026 | 117,201 | 1,909,918 | - | 2.5 | 293,003 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director | 12 Jan 2026 | 117,201 | 850,338 | - | - | Stock Option (right to buy) | ||
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.08 per share. | 21 Nov 2025 | 68,655 | 1,403,651 | - | 10.1 | 692,132 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.60 per share. | 17 Nov 2025 | 1,000,000 | 1,472,306 | - | 10.6 | 10,595,300 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, Chief Executive Officer | 17 Nov 2025 | 727,950 | 0 | - | - | Stock Option (right to buy) | ||
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.05 per share. | 17 Nov 2025 | 727,950 | 2,403,190 | - | 0.1 | 36,398 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.98 per share. | 17 Nov 2025 | 202,934 | 1,675,240 | - | 1.0 | 198,875 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, Chief Executive Officer | 17 Nov 2025 | 202,934 | 0 | - | - | Stock Option (right to buy) | ||
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, Chief Executive Officer | 17 Nov 2025 | 41,653 | 0 | - | - | Stock Option (right to buy) | ||
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.62 per share. | 17 Nov 2025 | 41,653 | 2,472,306 | - | 0.6 | 25,825 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, Chief Executive Officer | 17 Nov 2025 | 27,463 | 180,802 | - | - | Stock Option (right to buy) | ||
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.62 per share. | 17 Nov 2025 | 27,463 | 2,430,653 | - | 0.6 | 17,027 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 6.82 per share. | 21 Aug 2025 | 65,654 | 1,472,306 | - | 6.8 | 447,511 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.43 per share. | 21 May 2025 | 69,786 | 1,812,235 | - | 2.4 | 169,720 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2025 | 599,400 | 1,882,021 | - | 0 | Common stock | |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 3.13 per share. | 21 Feb 2025 | 34,353 | 1,282,621 | - | 3.1 | 107,635 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.96 per share. | 21 Nov 2024 | 33,779 | 1,316,974 | - | 2.0 | 66,362 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, Chief Executive Officer | 23 Oct 2024 | 1,974,502 | 1,974,502 | - | - | Stock Option (right to buy) | ||
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, Chief Executive Officer | 23 Oct 2024 | 1,171,476 | 1,171,476 | - | - | Stock Option (right to buy) | ||
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, Chief Executive Officer | 23 Oct 2024 | 967,539 | 967,539 | - | - | Stock Option (right to buy) | ||
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, Chief Executive Officer | 23 Oct 2024 | 208,265 | 208,265 | - | - | Stock Option (right to buy) | ||
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, Chief Executive Officer | 23 Oct 2024 | 208,264 | 208,264 | - | - | Stock Option (right to buy) | ||
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, Chief Executive Officer | 23 Oct 2024 | 202,934 | 202,934 | - | - | Stock Option (right to buy) | ||
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, Chief Executive Officer | 23 Oct 2024 | 41,653 | 41,653 | - | - | Stock Option (right to buy) | ||
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.04 per share. | 21 Aug 2024 | 33,333 | 1,350,753 | - | 1.0 | 34,666 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 1.33 per share. | 21 May 2024 | 19,973 | 1,399,697 | - | 1.3 | 26,516 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 1.36 per share. | 21 May 2024 | 15,611 | 1,384,086 | - | 1.4 | 21,169 | Common stock |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2024 | 1,419,670 | 1,419,670 | - | 0 | Common stock | |
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, See Remarks | 14 Sep 2022 | 1,455,901 | 1,455,901 | - | - | Stock Option (right to buy) | ||
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, See Remarks | 14 Sep 2022 | 727,950 | 727,950 | - | - | Stock Option (right to buy) | ||
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, See Remarks | 14 Sep 2022 | 727,950 | 727,950 | - | - | Stock Option (right to buy) | ||
| Amprius Tech Inc | Dr. Kang Sun, PhD | Director, See Remarks | 14 Sep 2022 | 545,962 | 545,962 | - | - | Stock Option (right to buy) |